
https://www.science.org/content/blog-post/stream-consciousness
# Stream of Consciousness (February 2006)

## 1. SUMMARY

This is a first-person narrative from a medicinal chemist working on synthesizing novel sulfonamides attached to heterocyclic ring systems. The author describes attempting to make compounds that have no prior literature examples, dealing with solubility issues when samples won't dissolve properly in methanol for LC/MS analysis, and reflects on their graduate school experiences with quantum mechanics courses. The stream-of-consciousness style captures the frustrations of synthetic chemistry work: unreliable suppliers (a reagent from "Big Jim's Discount Chemicals" that never arrived after a month and a half), outdated inventory systems sending automated emails about overdue orders, and workplace safety concerns (noting benzidine's carcinogenic properties and how safety standards have since tightened). The tone is informal and captures the daily reality of drug discovery research rather than presenting formal scientific findings.

## 2. HISTORY

This appears to be a blog post or personal narrative rather than a formal scientific article. The author blogs under the name "Derek Lowe," and this piece comes from what was likely a pharmaceutical industry blog from the mid-2000s. The chemical challenges described - synthesis of novel sulfonamide-heterocycle combinations, solubility problems, supplier delays, and reactions running cloudy or not dissolving properly - are standard issues in medicinal chemistry that remain relevant today. The safety concern about benzidine reflects how chemical safety practices have evolved over time; benzidine remains a known human carcinogen, and modern laboratories have far stricter controls, purchase restrictions, and safety protocols than were common in earlier decades. The underlying synthetic target (sulfonamides on heterocyclic systems) represents ongoing medicinal chemistry work on privileged scaffolds in drug discovery; while specific compounds mentioned in this informal piece aren't identifiable, the general approach continues to be widely used. Advances since 2006 include improved analytical techniques, the growth of commercial chemical suppliers that have made "Big Jim's Discount Chemicals"-style issues less common, and significant improvements in inventory and order-tracking systems that address the IT complaints mentioned.

## 3. PREDICTIONS

The article does not contain explicit forward-looking predictions or forecasts. It is a reflective, first-person account of daily medicinal chemistry work and does not attempt to anticipate future scientific developments or industry trends.

## 4. INTEREST

Rating: **3/10**

This is a personal blog entry capturing the day-to-day frustrations of drug discovery work rather than a scientific article with broader implications. While it gives some insight into medicinal chemistry work culture, it lacks specific compounds, data, or testable claims that would enable substantive analysis of later developments.

## 5. REFLECTIONS

The informal nature of this "article" makes traditional analysis difficult, as it's essentially a blog post about the daily grind of synthetic organic chemistry rather than research findings or industry analysis. The author describes real challenges in drug discovery (solubility issues, reagent procurement problems, safety concerns) that remain relevant, but there are no specific hypotheses, compounds, or claims to evaluate against subsequent developments. In hindsight, this type of science blogging became more common and influential in the late 2000s and 2010s as scientists began sharing their experiences more openly online, contributing to public understanding of how scientific research actually works behind the scenes.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20060205-stream-consciousness.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_